Cresemba (isavuconazole) — Blue Cross Blue Shield of Illinois

Initial criteria

• Patient has a diagnosis of invasive aspergillosis OR invasive mucormycosis OR another FDA labeled indication for the requested agent and route OR another compendia-supported indication for the requested agent and route
• Patient does NOT have any FDA labeled contraindications to the requested agent

Approval duration

6 months; 12 months if Ohio Fully Insured or HIM Shop